Zimmer Biomet Q1 Adjusted Earnings Fall, Revenue Rises; 2025 Outlook Updated

MT Newswires Live
May 05

Zimmer Biomet Holdings (ZBH) reported Q1 adjusted earnings Monday of $1.81 per diluted share, down from $1.94 a year earlier.

Analysts polled by FactSet expected $1.77.

Net sales for the quarter ended March 31 were $1.91 billion, up from $1.89 billion a year earlier.

Analysts surveyed by FactSet expected $1.9 billion.

The company said it now expects full-year adjusted EPS of $7.90 to $8.10, compared with its previous outlook range of $8.15 to $8.35.

Analysts polled by FactSet expect $8.19.

Zimmer said it now forecasts full-year revenue growth of 5.7% to 8.2%, up from its prior guidance of 1% to 3.5% increase.

The company's shares were up 1.5% in recent premarket activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10